In collaboration with Cleveland Clinic, University of British Columbia, and the Nebraska Nanomedicine Production Plant, ProTransit is scaling-up Pro-NP production and finalizing the formulation in preparation for further pre-clinical studies in the treatment of acute spinal cord injuries.  See attached press releases from UNMC :https://www.unmc.edu/news.cfm?match=20074; and the Omaha World Herald: http://www.omaha.com/livewellnebraska/million-grant-will-help-omaha-startup-test-spine-injury-treatment/article_b8779986-71d9-57f6-a269-c92497c33e0c.html. [/fusion_text]